TickerFacts.

Bicara Therapeutics Inc. (BCAX): R&D Expense

Annual figures by period end, from SEC filings.

$63.60M
Year ended 2024-12-31
2023-12-31: $30.60M2024-12-31: $63.60M$63.60M
2023-12-31 R&D Expense (USD) 2024-12-31
Period endedR&D ExpenseChange YoYSource filing
2024-12-31$63.60M+107.8%2025-03-27, From 2024-01-01
2023-12-31$30.60Mn/a2025-03-27, From 2023-01-01